LEADING

📅 Upcoming

🕒 Recent(90d)

News

• This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree
  RA Capital has already participated in four biotech financings in September. Meanwhile, Janus Henderson has been the year's most prolific backer of biotech reverse merger deals, according to Gilmar…
  biopharma_dive · 1d ago
• Boycott launched against American Diabetes Association includes journal
  Trump's $500 Obamacare promise, childhood cancer treatment with long-term risks, and more health news
  stat · 1d ago
• In first interview as FDA oncology chief, Angelo de Claro vows to ‘continue the innovation’ behind OCE legacy
  In his first interview after taking the reins of the FDA’s Oncology Center of Excellence, Angelo de Claro, M.D., is outlining a regulatory agenda that prioritizes organizational strength and contin…
  fiercebiotech · 1d ago
• Takeda’s long-term R&D head announces exit after major pipeline reorganization
  A few months after a new CEO stepped up to helm Takeda, the drugmaker will now have to prepare for another leadership change as its long-time R&D head plans his exit.
  biospace · 1d ago
• Andy Plump, architect of Takeda’s R&D overhaul, to retire next year
  Plump joined Takeda during a turbulent period, pushed the company to work more closely with young biotechs and will leave it with what CEO Julie Kim called a “lasting foundation.”
  biopharma_dive · 2d ago
• FDA places partial hold on Biohaven's ion channel drug
  The FDA has placed a troubled Biohaven program on partial clinical hold, the company disclosed Wednesday. An epilepsy study of the experimental drug called BHV-7000 was paused after regulators requ…
  endpoints · 2d ago
• STAT+: Cancer medicines remain in short supply across the U.S., survey finds
  An ongoing shortage of cancer medications continues to force leading cancer centers around the U.S. to seek work-around strategies to treat patients and a majority also report that clinical trials…
  stat · 2d ago
• From process to intelligence: How AI is reshaping people strategy in life sciences
  Applying artificial intelligence and automation tactics has played a large role in talent strategy conversations in the past few years. While many organizations initially focused on experimenting w…
  biospace · 2d ago
• Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules
  Medical Action Industries is correcting epidural kits containing recalled Huons Co. sodium chloride ampules.
  fda_medwatch · 2d ago
• Merck adds 53 to New Jersey chopping block
  Follow along as BioSpace tracks job cuts and restructuring initiatives.
  biospace · 2d ago